Welcome to LookChem.com Sign In|Join Free

CAS

  • or

248602-44-0

Post Buying Request

248602-44-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

248602-44-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 248602-44-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,8,6,0 and 2 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 248602-44:
(8*2)+(7*4)+(6*8)+(5*6)+(4*0)+(3*2)+(2*4)+(1*4)=140
140 % 10 = 0
So 248602-44-0 is a valid CAS Registry Number.

248602-44-0Downstream Products

248602-44-0Relevant articles and documents

Modular Design of Membrane-Active Antibiotics: From Macromolecular Antimicrobials to Small Scorpionlike Peptidomimetics

Wang, Minghui,Feng, Xiaoqian,Gao, Ruixuan,Sang, Peng,Pan, Xin,Wei, Lulu,Lu, Chao,Wu, Chuanbin,Cai, Jianfeng

, p. 9894 - 9905 (2021)

Infections caused by multidrug-resistant bacteria have emerged in recent decades, leading to escalating interest in host defense peptides (HDPs) to reverse this dangerous trend. Inspired by the modular design in bioengineering, herein we report a new class of small amphiphilic scorpionlike peptidomimetics based on this strategy. These HDP mimics show potent antimicrobial activity against both Gram-positive and Gram-negative bacteria without drug resistance but with a high therapeutic index. The membrane-compromising action mode was suggested to be their potential bactericidal mechanism. Pharmacodynamic experiments were conducted using a murine abscess model of methicillin-resistantStaphylococcus aureus(MRSA) infections. The lead compound 12 showed impressive in vivo therapeutic efficacy with ~99.998% (4.7log) reduction in skin MRSA burden, a significantly higher bactericidal efficiency than ciprofloxacin, and good biocompatibility. These results highlight the potential of these HDP mimics as novel antibiotic therapeutics.

Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents

-

, (2008/06/13)

Novel membrane-forming amphiphilic lipopeptides comprising one or more peptide moieties containing 2-50 aminoacyl residues and one or more hydrocarbon chains containing 5-50 carbon atoms. Such lipopeptides may be used in the formation of stabilized gas microbubble dispersions suitable for use as diagnostic and/or therapeutic agents, for example as ultrasound contrast agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 248602-44-0